AVTR vs BIO
As of Sep 20, 2026, Avantor (AVTR) scores 5.3/10 and Bio-Rad Laboratories (BIO) 7.4/10 on AlphaStocks' five-model composite, so BIO scores higher. AVTR trades 31% below its model fair value.
AVTR
Avantor, Inc.
5.3
Consider Buy
$15.52
BIO
BIO-RAD LABORATORIES, INC.
7.4
Consider Buy
$375.68
AVTR vs BIO: Which is the Better Investment?
Avantor, Inc. (AVTR) scores 5.3/10 while BIO-RAD LABORATORIES, INC. (BIO) scores 7.4/10 on AlphaStocks' composite model. BIO-RAD LABORATORIES, INC. has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | AVTR | BIO |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 5.3/10 | 7.4/10▲ |
| Rating | Consider Buy | Consider Buy▲ |
| Price | $15.52 | $375.68 |
| P/E Ratio | — | 13.5 |
| ROE | -9.5% | 9.7%▲ |
| Market Cap | $11B | $10B |
| Fair Value | $22.38 | — |
| Dividend Yield | — | — |
| Sector Rank | #95 of 168 | #7 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Caution | Neutral▲ |
| Graham | Caution | Attractive▲ |
| Lynch | Attractive | Attractive |
| Greenblatt | Caution | Strong▲ |
Related comparisons
AVTR vs BIO: Which Stock Scores Higher?
Avantor, Inc. (AVTR) and BIO-RAD LABORATORIES, INC. (BIO) are both in the Health Care sector. BIO currently leads with a composite score of 7.4/10 (Consider Buy) compared to AVTR's 5.3/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer